Hendrickx, Gretl http://orcid.org/0000-0001-6715-9241
Boudin, Eveline http://orcid.org/0000-0003-4818-6804
Mateiu, Ligia http://orcid.org/0000-0002-2655-3581
Yorgan, Timur A. http://orcid.org/0000-0002-0712-0983
Steenackers, Ellen
Kneissel, Michaela
Kramer, Ina
Mortier, Geert http://orcid.org/0000-0001-9871-4578
Schinke, Thorsten http://orcid.org/0000-0002-8576-0177
Van Hul, Wim http://orcid.org/0000-0002-5065-7858
Funding for this research was provided by:
Fonds Wetenschappelijk Onderzoek (G031915N, 12A3814N)
Universiteit Antwerpen (GENOMED, FFB190208)
Seventh Framework Programme (SYBIL, 602300)
Article History
Received: 10 July 2023
Accepted: 31 October 2023
First Online: 5 December 2023
Declarations
:
: GH, EB, LM, TAY, ES, GM, TS and WVH declare that they have no conflict of interest. MK and IK are employees of Novartis Institutes for BioMedical Research.
: All animal experimental procedures were carried out in compliance with the ARRIVE guidelines and European Commission Council Directive 2010/63/EU on protecting animals for scientific purposes and ethical approval for all procedures was obtained by the University of Antwerp Ethics Committee (Reference Number 2017-60).
: All animal experimental procedures were carried out in compliance with the ARRIVE guidelines and were approved by the University of Antwerp Ethics Committee (reference number 2017-60).
: No informed consent statement.